Chimeric antigen receptor T-cell (CAR-T) therapy, whereby autologous T cells are genetically engineered to recognize and eliminate tumor cells in vivo, has revolutionized cancer care since the first ...

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...

Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR ...

The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...